Follow-up of thyroid cancer patients with favorable prognostic indicators.
Leboulleux
S
S
Service de Médecine Nucléaire et de Cancérologie Endocrinienne Institut Gustave Roussy, 94805 Villejuif Cedex, France.
Baudin
E
E
Schlumberger
M
M
D018263:Adenocarcinoma, Follicular / Q000175:diagnosis / Q000628:therapy; D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D013974:Thyroxine / Q000627:therapeutic use
D007457:Iodine Radioisotopes; D013954:Thyroglobulin; D013974:Thyroxine